BLFE OTC
BioLife Sciences Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range0.0001-0.01
Volume911
Avg Volume75,525
Beta-2290.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJustin De Four
Employees3
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2005-04-25
Websitebiolifesciences.com
2831 Saint Rose Parkway
Henderson, NV 89052
US
Henderson, NV 89052
US
833-919-1037
About BioLife Sciences Inc.
BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, ultraviolet (UV) sterilization equipment, professional electrostatic disinfection services, specialized anti-microbial fabrics, and innovative touch-free vending or marketplace systems. The company, which was established in 2018, operates from its base in Mississauga, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found